611 related articles for article (PubMed ID: 17293108)
1. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
Barthel TK; Mathern DR; Whitfield GK; Haussler CA; Hopper HA; Hsieh JC; Slater SA; Hsieh G; Kaczmarska M; Jurutka PW; Kolek OI; Ghishan FK; Haussler MR
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):381-8. PubMed ID: 17293108
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
4. The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis.
Haussler MR; Whitfield GK; Kaneko I; Forster R; Saini R; Hsieh JC; Haussler CA; Jurutka PW
Rev Endocr Metab Disord; 2012 Mar; 13(1):57-69. PubMed ID: 21932165
[TBL] [Abstract][Full Text] [Related]
5. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.
Shimada T; Yamazaki Y; Takahashi M; Hasegawa H; Urakawa I; Oshima T; Ono K; Kakitani M; Tomizuka K; Fujita T; Fukumoto S; Yamashita T
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1088-95. PubMed ID: 15998839
[TBL] [Abstract][Full Text] [Related]
7. FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes.
Kaneko I; Saini RK; Griffin KP; Whitfield GK; Haussler MR; Jurutka PW
J Endocrinol; 2015 Sep; 226(3):155-66. PubMed ID: 26148725
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes.
Orfanidou T; Malizos KN; Varitimidis S; Tsezou A
Exp Biol Med (Maywood); 2012 Mar; 237(3):241-53. PubMed ID: 22393163
[TBL] [Abstract][Full Text] [Related]
9. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
Prié D; Friedlander G
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
[TBL] [Abstract][Full Text] [Related]
11. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Andrukhova O; Streicher C; Zeitz U; Erben RG
Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB
J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835
[TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of vitamin D action.
Haussler MR; Whitfield GK; Kaneko I; Haussler CA; Hsieh D; Hsieh JC; Jurutka PW
Calcif Tissue Int; 2013 Feb; 92(2):77-98. PubMed ID: 22782502
[TBL] [Abstract][Full Text] [Related]
17. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
18. 1ɑ,25-Dihydroxyvitamin D
Luo W; Jiang Y; Yi Z; Wu Y; Gong P; Xiong Y
J Cell Mol Med; 2021 Apr; 25(8):4148-4156. PubMed ID: 33609082
[TBL] [Abstract][Full Text] [Related]
19. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]